SEC Form 4 · accession 0001325812-15-000064
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry E Greene
Officer — President and COO
Period of report
Dec 18, 2015
Accepted (ET)
Dec 22, 2015 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 18, 2015 | G | 2,100 | $0.00 | D | 48,264 | D | |
| Common StockF2 | holding | — | — | — | 2,621 | I | by Managed Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $88.95 | Dec 18, 2015 | A | 40,000 | A | — | Dec 18, 2025 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The reporting person gifted 2,100 shares to the Ayco Charitable Foundation.
- F2The reporting person owns 2,621 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- F3The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.